The anticoagulant treatment dilemma in pulmonary embolism associated to cancer Cover

.blurhash-client-img { display: none !important; }

The anticoagulant treatment dilemma in pulmonary embolism associated to cancer

Volume 72 (2023): Issue 1 (January 2023)

By: Daniela Maria Nemtut, Cornel Adrian Petreanu and Ruxandra Ulmeanu

Open Access

|Jun 2024

Authors

Daniela Maria Nemtut

danyellaroman@gmail.com

Cardiology Department of Pelican Clinical Hospital, Romania

Cornel Adrian Petreanu

Pneumology Institute “Marius Nasta” Bucharest, Thoracic Surgery Dept

Ruxandra Ulmeanu

North Hospital, Provita Medical Group, Bucharest, Bronchoscopy Dept

Faculty of Medicine Oradea

DOI: https://doi.org/10.2478/pneum-2024-0005 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993

Journal RSS Feed

Language: English

Page range: 31 - 38

Published on: Jun 10, 2024

Published by: Romanian Society of Pneumology

In partnership with: Paradigm Publishing Services

Publication frequency: Volume open

Keywords:

pulmonary embolism,

recurrent pulmonary embolism,

anticoagulant treatment

Related subjects:

Clinical medicine,

Clinical medicine, other,

Internal medicine,

© 2024 Daniela Maria Nemtut, Cornel Adrian Petreanu, Ruxandra Ulmeanu, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 72 (2023): Issue 1 (January 2023)Next article